Lene Gerlach Ph.D Overview
- Company
- Synklino
- Primary Position
-
Board Observer
- Primary Industry
-
Healthcare
- Active Board Seats
-
2
- Med. Deal Size
-
- Med. Valuation
-
Lene Gerlach Ph.D General Information
Biography
Dr. Lene Gerlach serves as a Board Observer at Synklino. She also serves as a Board Member at Hoba Therapeutics. She served as a Partner at Eir Ventures. She served as Investment Manager, Early Engagement at VF Venture. She served as Chairperson at EYE-GO. She served as a Board Member at Northern VO. She served as a Board Member at VentriJect. She served as a Board Observer at Cerebriu and Chromologics. She served as a Board Member at Advanced Substrate Technologies. She is a former funds manager at Borean Innovation and has held several board seats throughout her career. Her primary competencies are within the medical field, and she holds a Ph.D. in Neuroscience from Copenhagen University. She served as a Board Member at Airloft. She is a VC specializing in Life Science investments with more than 25 years of experience within the life science industry as a research scientist (with a Ph.D. in Neuroscience), patent attorney, business developer, consultant on university spin-outs, Vice President in two biotech companies and 7 years as a venture capitalist having financed more than 35 companies, prepared follow-up capital rounds and executed company exits. She has extensive board experience having headed 18 companies as Chairman and 17 as a board member or observer. She is an investment manager at Vækstfonden, the Sovereign Wealth Fund of the Danish state.
Contact Information
Address
- Frederiksborggade 1. 2.th.
- 1360 Copenhagen
- Denmark
Lene Gerlach Ph.D Board Seats (2)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
Hoba Therapeutics | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Copenhagen, Denmark | |
Synklino | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Copenhagen, Denmark |
Lene Gerlach Ph.D Lead Partner on Deals (8)
Lene Gerlach Ph.D has been the lead partner on 8 deals. Their latest deal was with Hoba Therapeutics, a drug discovery company. The deal was made for on 11-Dec-2023.
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
Hoba Therapeutics | 11-Dec-2023 | Later Stage VC (Series A) | Completed | Drug Discovery | Copenhagen, Denmark | |
Dania Therapeutics | 18-Oct-2023 | Completed | Drug Discovery | Hellerup, Denmark | ||
Hoba Therapeutics | 07-Jul-2022 | Completed | Drug Discovery | Copenhagen, Denmark | ||
CathVision | 07-Jul-2017 | Completed | Diagnostic Equipment | Copenhagen, Denmark | ||
Hoba Therapeutics | 02-Dec-2016 | Completed | Drug Discovery | Copenhagen, Denmark | ||
Paqle | 01-Jun-2014 | Completed | Information Services (B2C) | Copenhagen, Denmark | ||
CathVision | Accelerator/Incubator | Completed | Diagnostic Equipment | Copenhagen, Denmark | ||
Northern VO | Accelerator/Incubator | Completed | Other Commercial Services | Lyngby, Denmark |
Lene Gerlach Ph.D Network (98)
Board Members (76)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Jonas Ahm-Lundgren | Octarine Bio | The Footprint Firm | Copenhagen, Denmark | |
Jarne Elleholm | Chromologics | Self | Copenhagen, Denmark | |
VentriJect | Self | Copenhagen, Denmark | ||
Synklino | Self | Copenhagen, Denmark | ||
Hoba Therapeutics | Self | Copenhagen, Denmark |
Portfolio Executives (17)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Kenneth Petersen Ph.D | Hoba Therapeutics | Co-Founder, Chief Operating Officer & CDO | 11-Dec-2023 | Copenhagen, Denmark |
Torsten Madsen Ph.D | Hoba Therapeutics | Chief Executive Officer | 11-Dec-2023 | Copenhagen, Denmark |
Hoba Therapeutics | Chief Scientific Officer | 11-Dec-2023 | Copenhagen, Denmark | |
Hoba Therapeutics | Chief Financial Officer | 11-Dec-2023 | Copenhagen, Denmark | |
Dania Therapeutics | Co-Founder & Board Member | 18-Oct-2023 | Hellerup, Denmark |
Fund Team Members (5)
Name | Investor | Fund | Fund Location |
---|---|---|---|
Stephan Christgau Ph.D | Eir Ventures | Eir Ventures Life Science Fund | Stockholm, Sweden |
Lovisa Backemar Ph.D | Eir Ventures | Eir Ventures Life Science Fund | Stockholm, Sweden |
Eir Ventures | Stockholm, Sweden | ||
Eir Ventures | Stockholm, Sweden | ||
Eir Ventures | Stockholm, Sweden |
Lene Gerlach Ph.D Affiliated Funds (1)
Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
---|---|---|---|---|---|---|---|---|
Eir Ventures Life Science Fund | Eir Ventures | Venture - General | Closed | 2020 |
Lene Gerlach Ph.D FAQs
-
Who is Lene Gerlach Ph.D?
Dr. Lene Gerlach serves as a Board Observer at Synklino.
-
How much does Lene Gerlach Ph.D typically invest?
Lene Gerlach Ph.D's median deal size is
. -
What is Lene Gerlach Ph.D’s main position?
Lene Gerlach Ph.D’s primary position is Board Observer.
-
How many active board seats does Lene Gerlach Ph.D hold?
Lene Gerlach Ph.D holds 2 board seats including Hoba Therapeutics and Synklino.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »